SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Theodorsson Elvar) "

Sökning: WFRF:(Theodorsson Elvar)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Dock, Hua, et al. (författare)
  • DNA Methylation Inhibitor Zebularine Confers Stroke Protection in Ischemic Rats
  • 2015
  • Ingår i: TRANSLATIONAL STROKE RESEARCH. - Springer Verlag (Germany). - 1868-4483. ; 6:4, s. 296-300
  • Tidskriftsartikel (refereegranskat)abstract
    • 5-Aza-deoxycytidine (5-aza-dC) confers neuroprotection in ischemic mice by inhibiting DNA methylation. Zebularine is another DNA methylation inhibitor, less toxic and more stable in aqueous solutions and, therefore more biologically suitable. We investigated Zebularines effects on brain ischemia in a rat middle cerebral artery occlusion (MCAo) model in order to elucidate its therapeutic potential. Male Wistar wild-type (WT) rats were randomly allocated to three treatment groups, vehicle, Zebularine 100 mu g, and Zebularine 500 mu g. Saline (10 mu L) or Zebularine (10 mu L) was administered intracerebroventricularly 20 min before 45-min occlusion of the middle cerebral artery. Reperfusion was allowed after 45-min occlusion, and the rats were sacrificed at 24-h reperfusion. The brains were removed, sliced, and stained with 2 % 2,3,5-triphenyltetrazolium chloride (TTC) before measuring infarct size. Zebularine (500 mu g) reduced infarct volumes significantly (p less than 0.05) by 61 % from 20.7 +/- 4.2 % in the vehicle treated to 8.1 +/- 1.6 % in the Zebularine treated. Zebularine (100 mu g) also reduced infarct volumes dramatically by 55 to 9.4 +/- 1.2 %. The mechanisms behind this neuroprotection is not yet known, but the results agree with previous studies and support the notion that Zebularine-induced inhibition of DNA methyltransferase ameliorates ischemic brain injury in rats.
  •  
2.
  • Hilke, Susanne, et al. (författare)
  • Estrogen induces a rapid increase in galanin levels in female rat hippocampal formation : possibly a nongenomic/indirect effect
  • 2005
  • Ingår i: European Journal of Neuroscience. - 0953-816X. ; 21:8, s. 2089-2099
  • Tidskriftsartikel (refereegranskat)abstract
    • Administration of 17?-estradiol to ovariectomized rats increased the concentrations of galanin-like immunoreactivity (LI) in the hippocampal formation by 215% (P < 0.001) within 1 h. An increase of 125% (P < 0.05) was observed in the same brain region in the proestrous phase of a normal estrous cycle. Tamoxifen® did not block the 17?-estradiol-induced increase in the concentration of galanin-LI but resulted in a 62% decrease in the hypothalamus within 1 h. In vivo microdialysis in the dorsal hippocampal formation showed a decrease of extracellular galanin-LI (P < 0.001) 1?2 h after treatment with 17?-estradiol, indicating a decreased release of galanin. For comparision, we studied the concentrations of neuropeptide Y, which were not influenced significantly in any of the regions studied. Taken together our results suggest that 17?-estradiol inhibits galanin release, presumably from noradrenergic nerve terminals, and primarily via a nongenomic/indirect action, not necessarily involving the classical nuclear receptors ER-? or ER-?. These rapid estrogen-induced changes in galanin release could influence transmitter signalling and plasticity in the hippocampal formation.
  •  
3.
  •  
4.
  • Ingberg, Edvin, et al. (författare)
  • Effects of high and low 17 beta-estradiol doses on focal cerebral ischemia in rats
  • 2016
  • Ingår i: Scientific Reports. - NATURE PUBLISHING GROUP. - 2045-2322. ; 6:20228
  • Tidskriftsartikel (refereegranskat)abstract
    • The majority of the numerous animal studies of the effects of estrogens on cerebral ischemia have reported neuroprotective results, but a few have shown increased damage. Differences in hormone administration methods, resulting in highly different 17 beta-estradiol levels, may explain the discrepancies in previously reported effects. The objective of the present study was to test the hypothesis that it is the delivered dose per se, and not the route and method of administration, that determines the effect, and that high doses are damaging while lower doses are protective. One hundred and twenty ovariectomized female Wistar rats (n = 40 per group) were randomized into three groups, subcutaneously administered different doses of 17 beta-estradiol and subjected to transient middle cerebral artery occlusion. The modified sticky tape test was performed after 24 h and the rats were subsequently sacrificed for infarct size measurements. In contrast to our hypothesis, a significant negative correlation between 17 beta-estradiol dose and infarct size was found (p = 0.018). Thus, no support was found for the hypothesis that 17 beta-estradiol can be both neuroprotective and neurotoxic merely depending on dose. In fact, on the contrary, the findings indicate that the higher the dose of 17 beta-estradiol, the smaller the infarct.
5.
  • Ingberg, Edvin, 1988-, et al. (författare)
  • Effects of high and low 17β-estradiol doses on focal cerebral ischemia in rats
  • 2016
  • Annan publikation (övrigt vetenskapligt)abstract
    • The majority of the numerous animal studies of the effects of estrogens on cerebral ischemia have reported neuroprotective results, but a few have shown increased damage. Differences in hormone administration methods, resulting in highly different 17β-estradiol levels, may explain the discrepancies in previously reported effects. The objective of the present study was to test the hypothesis that it is the delivered dose per se, and not the route and method of administration, that determines the effect, and that high doses are damaging while lower doses are protective. One hundred and twenty ovariectomized female Wistar rats (n=40 per group) were randomized into three groups, subcutaneously administered different doses of 17β-estradiol and subjected to transient middle cerebral artery occlusion. The modifi ed sticky tape test was performed after 24 h and the rats were subsequently sacrifi ced for infarct size measurements. In contrast to our hypothesis, a signifi cant negative correlation between 17β-estradiol dose and infarct size was found (p=0.018). Thus, no support was found for the hypothesis that 17β-estradiol can be both neuroprotective and neurotoxic merely depending on dose. In fact, on the contrary, the fi ndings indicate that the higher the dose of 17β-estradiol, the smaller the infarct.
  •  
6.
  • Ingberg, Edvin, et al. (författare)
  • Elevated body swing test after focal cerebral ischemia in rodents: methodological considerations
  • 2015
  • Ingår i: BMC neuroscience (Online). - BioMed Central / Springer Verlag (Germany). - 1471-2202. ; 16:50
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: The elevated body swing test (EBST) is a behavioral test used to evaluate experimental stroke in rodents. The basic idea is that when the animal is suspended vertically by the tail, it will swing its head laterally to the left or right depending on lesion side. In a previous study from our lab using the EBST after middle cerebral artery occlusion (MCAo), rats swung contralateral to the infarct day 1 post-MCAo, but ipsilateral day 3 post-MCAo. This shift was unexpected and prompted us to perform the present study. First, the literature was systematically reviewed to elucidate whether a similar shift had been noticed before, and if consensus existed regarding swing direction. Secondly, an experiment was conducted to systematically investigate the suggested behavior. Eighty-three adult male and female Sprague-Dawley rats were subjected to MCAo or sham surgery and the EBST was performed up to 7 days after the lesion. Results: Both experimentally and through systematic literature review, the present study shows that the direction of biased swing activity in the EBST for rodents after cerebral ischemia can differ and even shift over time in some situations. The EBST curve for females was significantly different from that of males after the same occlusion time (p = 0.023). Conclusions: This study highlights the importance of adequate reporting of behavioral tests for lateralization and it is concluded that the EBST cannot be recommended as a test for motor asymmetry after MCAo in rats.
7.
  • Ingberg, Edvin, 1988-, et al. (författare)
  • Method parameters’ impact on mortality and variability in mouse stroke experiments a meta-analysis
  • 2016
  • Ingår i: Scientific Reports. - Nature Publishing Group. - 2045-2322. ; 6
  • Tidskriftsartikel (refereegranskat)abstract
    • Although hundreds of promising substances have been tested in clinical trials, thrombolysis currently remains the only specifi c pharmacological treatment for ischemic stroke. Poor quality, e.g. low statistical power, in the preclinical studies has been suggested to play an important role in these failures. Therefore, it would be attractive to use animal models optimized to minimize unnecessary mortality and outcome variability, or at least to be able to power studies more exactly by predicting variability and mortality given a certain experimental setup. The possible combinations of methodological parameters are innumerous, and an experimental comparison of them all is therefore not feasible. As an alternative approach, we extracted data from 334 experimental mouse stroke articles and, using a hypothesis-driven meta-analysis, investigated the method parameters’ impact on infarct size variability and mortality. The use of Swiss and C57BL6 mice as well as permanent occlusion of the middle cerebral artery rendered the lowest variability of the infarct size while the emboli methods increased variability. The use of Swiss mice increased mortality. Our study offers guidance for researchers striving to optimize mouse stroke models.
8.
  • Isaksson, Ida-Maria, et al. (författare)
  • Methods for 17 beta-oestradiol administration to rats
  • 2011
  • Ingår i: Scandinavian Journal of Clinical and Laboratory Investigation. - Informa Healthcare. - 0036-5513. ; 71:7, s. 583-592
  • Tidskriftsartikel (refereegranskat)abstract
    • Several studies indicate that the beneficial or harmful effects of oestrogens in stroke are dose-dependent. Rats are amongst the most frequently used animals in these studies, which calls for thoroughly validated methods for administering 17 beta-oestradiol to rats. In an earlier study we characterised three different administration methods for 17 beta-oestradiol over 42 days. The present study assesses the concentrations in a short time perspective, with the addition of a novel peroral method. Female Sprague-Dawley rats were ovariectomised and administered 17 beta-oestradiol by subcutaneous injections, silastic capsules, pellets and orally (in the nut-cream Nutella (R)), respectively. One group received 17 beta-oestradiol by silastic capsules without previous washout time. Blood samples were obtained after 30 minutes, 1, 2, 4, 8, 12, 24, 48 and 168 hours and serum 17 beta-oestradiol (and oestrone sulphate in some samples) was subsequently analysed. For long-term characterisation, one group treated perorally was blood sampled after 2, 7, 14, 21, 28, 35 and 42 days. At sacrifice, uterine horns were weighed and subcutaneous tissue samples were taken for histological assessment. The pellets, silastic capsule and injection groups produced serum 17 beta-oestradiol concentrations that were initially several orders of magnitude higher than physiological levels, while the peroral groups had 17 beta-oestradiol levels that were within the physiological range during the entire experiment. The peroral method is a promising option for administering 17 beta-oestradiol if physiological levels or similarity to womens oral hormone therapy are desired. Uterine weights were found to be a very crude measure of oestrogen exposure.
  •  
9.
  • Isaksson, Ida-Maria, et al. (författare)
  • Methods for 17?-oestradiol administration to rats
  • 2011
  • Ingår i: Scandinavian Journal of Clinical and Laboratory Investigation. - Informa Healthcare. - 0036-5513. ; 71:7, s. 583-592
  • Tidskriftsartikel (refereegranskat)abstract
    • Several studies indicate that the beneficial or harmful effects of oestrogens in stroke are dose-dependent. Rats are amongst the most frequently used animals in these studies, which calls for thoroughly validated methods for administering 17?-oestradiol to rats. In an earlier study we characterised three different administration methods for 17?-oestradiol over 42 days. The present study assesses the concentrations in a short time perspective, with the addition of a novel peroral method. Female Sprague-Dawley rats were ovariectomised and administered 17?-oestradiol by subcutaneous injections, silastic capsules, pellets and orally (in the nut-cream Nutella®), respectively. One group received 17?-oestradiol by silastic capsules without previous washout time. Blood samples were obtained after 30 minutes, 1, 2, 4, 8, 12, 24, 48 and 168 hours and serum 17?-oestradiol (and oestrone sulphate in some samples) was subsequently analysed. For long-term characterisation, one group treated perorally was blood sampled after 2, 7, 14, 21, 28, 35 and 42 days. At sacrifice, uterine horns were weighed and subcutaneous tissue samples were taken for histological assessment. The pellets, silastic capsule and injection groups produced serum 17?-oestradiol concentrations that were initially several orders of magnitude higher than physiological levels, while the peroral groups had 17?-oestradiol levels that were within the physiological range during the entire experiment. The peroral method is a promising option for administering 17?-oestradiol if physiological levels or similarity to women's oral hormone therapy are desired. Uterine weights were found to be a very crude measure of oestrogen exposure.
  •  
10.
  • Isaksson, Ida-Maria, et al. (författare)
  • Methods for 17β-oestradiol administration to rats.
  • 2011
  • Ingår i: Scandinavian Journal of Clinical and Laboratory Investigation. - London, United Kingdom : Informa Healthcare. - 0036-5513. ; 71:7, s. 583-592
  • Tidskriftsartikel (refereegranskat)abstract
    • Several studies indicate that the beneficial or harmful effects of oestrogens in stroke are dose-dependent. Rats are amongst the most frequently used animals in these studies, which calls for thoroughly validated methods for administering 17β-oestradiol to rats. In an earlier study we characterised three different administration methods for 17β-oestradiol over 42 days. The present study assesses the concentrations in a short time perspective, with the addition of a novel peroral method. Female Sprague-Dawley rats were ovariectomised and administered 17β-oestradiol by subcutaneous injections, silastic capsules, pellets and orally (in the nut-cream Nutella(®)), respectively. One group received 17β-oestradiol by silastic capsules without previous washout time. Blood samples were obtained after 30 minutes, 1, 2, 4, 8, 12, 24, 48 and 168 hours and serum 17β-oestradiol (and oestrone sulphate in some samples) was subsequently analysed. For long-term characterisation, one group treated perorally was blood sampled after 2, 7, 14, 21, 28, 35 and 42 days. At sacrifice, uterine horns were weighed and subcutaneous tissue samples were taken for histological assessment. The pellets, silastic capsule and injection groups produced serum 17β-oestradiol concentrations that were initially several orders of magnitude higher than physiological levels, while the peroral groups had 17β-oestradiol levels that were within the physiological range during the entire experiment. The peroral method is a promising option for administering 17β-oestradiol if physiological levels or similarity to women's oral hormone therapy are desired. Uterine weights were found to be a very crude measure of oestrogen exposure.
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (26)
Typ av publikation
tidskriftsartikel (123)
bokkapitel (14)
annan publikation (9)
konferensbidrag (6)
forskningsöversikt (6)
rapport (1)
visa fler...
samlingsverk (redaktörskap) (1)
recension (1)
visa färre...
Typ av innehåll
refereegranskat (107)
övrigt vetenskapligt (50)
populärvet., debatt m.m. (4)
Författare/redaktör
Theodorsson, Elvar (110)
Theodorsson, Elvar, ... (51)
Theodorsson, Annette ... (28)
Ström, Jakob O., 198 ... (11)
Hammar, Mats, (8)
Ström, Jakob, (8)
visa fler...
Hokfelt, T (7)
Hilke, Susanne, (7)
Rugarn, Olof (7)
Ingberg, Edvin, (7)
Nelson, Nina, (6)
Hammar, Mats, 1950-, (6)
Grankvist, Kjell, (5)
Ström, Jakob O (5)
Faresjö, Tomas, (5)
Spetz, Anna-Clara, 1 ... (5)
Lundeberg, T (4)
Hökfelt, Tomas (4)
Nilsson-Ehle, Peter (4)
Josefsson, Ann, (4)
Malm, Johan (4)
Ludvigsson, Johnny, (4)
Olsen Faresjö, Åshil ... (4)
Holm, Lovisa, 1962-, (4)
Isaksson, Ida-Maria, (4)
Karlén, Jerker, (4)
Blom, M. (3)
Ogren, SO, (3)
Tengvall, Pentti, (3)
Sydsjö, Gunilla, (3)
Angmar-Mansson, B (3)
Magnusson, Bertil, (3)
Stenfors, Carina, (3)
Mörelius, Evalotte, (3)
Landin, Britta, (3)
Nordlind, Klas, (3)
Faxälv, Lars (3)
Holmberg, K (3)
Dawidson, I (3)
Boknäs, Niklas, (3)
Ramström, Sofia, (3)
Kuteeva, E (3)
Lundeberg, Thomas (3)
Sjöberg, Folke, (2)
Eintrei, Christina, ... (2)
Hokfelt, Tomas (2)
Alstergren, P (2)
Hellstrom, PM (2)
Lindahl, Tomas L, (2)
Naslund, E, (2)
visa färre...
Lärosäte
Linköpings universitet (155)
Karolinska Institutet (24)
Örebro universitet (16)
Uppsala universitet (4)
Umeå universitet (4)
Göteborgs universitet (4)
visa fler...
Sveriges Lantbruksuniversitet (2)
swepub_uni:ri_t (2)
Röda Korsets Högskola (2)
Lunds universitet (1)
visa färre...
Språk
Engelska (131)
Svenska (25)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (155)
Naturvetenskap (8)
Lantbruksvetenskap (4)
Teknik (3)
Samhällsvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy